CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on HPV-Linked throat cancer
Disease control OngoingThis study is testing whether combining two immunotherapy drugs (ipilimumab and nivolumab) with a targeted course of radiation is safe and effective for treating advanced throat cancer caused by HPV. The goal is to help the body's immune system better recognize and attack the can…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 04:05 UTC
-
Could less radiation mean easier swallowing after throat cancer surgery?
Disease control OngoingThis study is testing if a lower dose of radiation after robotic throat cancer surgery can reduce long-term swallowing problems while still controlling the cancer. It's for people with HPV-positive throat cancer who have a low risk of recurrence based on a special blood test. The…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Could a lower radiation dose beat throat cancer with fewer side effects?
Disease control OngoingThis study is testing if a lower dose of radiation combined with an immunotherapy drug (nivolumab) works as well as the standard, higher-dose radiation combined with chemotherapy (cisplatin) for treating early-stage throat cancer linked to HPV in non-smokers. The goal is to contr…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC